An interventional study of Exercise training in COVID-19, Long COVID-19 and Cardiopulmonary Function, sponsored by Chulabhorn Hospital. Completed at 1 site in Thailand. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-06-05.
Sponsored by Chulabhorn Hospital · Not applicable, Interventional, and Treatment
This study aims to evaluate the effects of Physiotherapy Via Video Calls on Cardiopulmonary Functions, Physical Function, Cognitive Function, Activity Daily Livings, and Quality of Life in Patients With COVID-19.
A 2-armed, parallel-group, randomized controlled trial was conducted at Chulabhorn Hospital, Thailand on a convenience sample of patients who tested positive for COVID-19 using RT-PCR.
605 studies on the registry are indexed under Post-Acute COVID-19 Syndrome; 201 are open to participants now.
This study's enrollment of 32 is below the median of 60 across 417 interventional studies indexed under Post-Acute COVID-19 Syndrome.
Browse Post-Acute COVID-19 Syndrome studies →Chulabhorn Hospital is the lead sponsor of 4 studies on the registry; none are open to participants now.
Compared within Post-Acute COVID-19 Syndrome, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is COVID-19. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Receive an advice and a leaflet for cardiopulmonary rehabilitation.
Receive the physical therapy training via video call (Pulmonary training, Calisthenic exercise, Upper and lower limbs strengthening exercise, Core stabilizer exercise, Aerobic exercise) at day 3, 6, 9, 12, 16, and 21 after positive in COVID-19 testing and also receive advise and a leaflet for cardiopulmonary rehabilitation.
Behavioral: Exercise training
1. Physical therapy training via video call 2. An advise and a leaflet for cardiopulmonary rehabilitation
Cardiopulmonary function
using Cardiopulmonary exercise testing (CPET)
Time frame: at day 28 and 90 after positive in COVID-19 testing
Patient's quality of life
using the The World Health Organization Quality of Life (WHOQOL-BREF-THAI) 26 items; the final score ranges from 24-120; higher score means participants satisfied with the quality of life.
Time frame: at day 3 and 21 after positive in COVID-19 testing
Functional capacity
using Duke Activity status index The final score ranges between zero and 58.2 points; The higher the score, the better the functional capacity.
Time frame: at day 3 and 21 after positive in COVID-19 testing
Anxiety and depression
using Hospital Anxiety and Depression Scale (HADS) The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). A total subscale score of \>8 points out of a possible 21 denotes considerable symptoms of anxiety or depression.
Time frame: at day 3 and 21 after positive in COVID-19 testing
Insomnia
using Insomnia Severity Index (ISI) The final score ranges between zero and 28 points. The total score is interpreted as follows: absence of insomnia (0-7); sub-threshold insomnia (8-14); moderate insomnia (15-21); and severe insomnia (22-28).
Time frame: at day 3 and 21 after positive in COVID-19 testing
Cognitive function
using Thai Mental State Examination The final score ranges between zero and 30 points. A score of 25 or higher is classed as normal. If the score is below 24, the result is usually considered to be abnormal, indicating possible cognitive impairment.
Time frame: at day 3 and 21 after positive in COVID-19 testing
Muscle strength
using 1-minute sit to stand
Time frame: at day 3 and 21 after positive in COVID-19 testing
Plan to share: No — Due to the ethical restriction, investigators cannot share any individual participant data.
No publications or documents are linked to this record.
Ran from Feb 2024 to primary completion in Jun 2024, 3 months.
Of 233 non-industry interventional studies with no phase under Post-Acute COVID-19 Syndrome, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 28. This study's 3 months is below that.
Counting every sponsor, half of 244 studies reached it within 16 months; a quarter within 7 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Post-Acute COVID-19 Syndrome →
Chulabhorn Hospital